EX-10.3
Fulcrum Therapeutics, Inc.
AMENDMENT TO EMPLOYMENT AGREEMENT
This is an amendment (the “Amendment”) to the Executive Employment Agreement dated August 7, 2023 (the “Agreement”) by and between Fulcrum Therapeutics, Inc. (the “Company”) and Alan Musso (the “Executive”) (the Company and the Executive each a “Party” and together the “Parties”). This Amendment shall be effective on June 5, 2026 (the “Amendment EffectiveDate.”)
This Amendment supersedes any prior or contemporaneous agreement, communication or representation with, from or of the Company with respect to the terms described in this Amendment. Otherwise, with respect to all other terms, the Agreement remains in full force and effect. Capitalized but undefined terms in this Amendment are defined in the Agreement.
Executive’s Agreement is hereby amended as follows:
1.
A new Section 4(j) is hereby added to the Agreement, containing the following text:
…